DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
DANIQUIDONE
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
DANIQUIDONE
×
Maximum Phase:
1
First Approval:
None
UNII:
E780TX33D2
Molecule Type:
Small molecule
Molecular Formula:
C15H11N3O
Molecular Weight:
249.27
AlogP:
2.32
PSA:
58.69
HBD:
1.0
HBA:
#RotB:
0.0
Source:
ASP-5878
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
ASP-5878
×
Maximum Phase:
1
First Approval:
None
UNII:
C0Z095LL72
Molecule Type:
Small molecule
Molecular Formula:
C18H19F2N5O4
Molecular Weight:
407.38
AlogP:
2.28
PSA:
103.55
HBD:
2.0
HBA:
#RotB:
9.0
Source:
KANAMYCIN A
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
KANAMYCIN A
×
Maximum Phase:
1
First Approval:
None
UNII:
EQK9Q303C5
Molecule Type:
Small molecule
Molecular Formula:
C18H36N4O11
Molecular Weight:
484.5
AlogP:
-7.29
PSA:
282.61
HBD:
11.0
HBA:
#RotB:
6.0
Source:
PLX-51107
1
Small molecule
Investigational
Unknown
Unknown
Graft vs Host Disease
Unknown
PLX-51107
×
Maximum Phase:
1
First Approval:
None
UNII:
W758F1L9ND
Molecule Type:
Small molecule
Molecular Formula:
C26H22N4O3
Molecular Weight:
438.49
AlogP:
5.68
PSA:
94.04
HBD:
1.0
HBA:
#RotB:
5.0
Source:
PROPYL GALLATE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PROPYL GALLATE
×
Maximum Phase:
1
First Approval:
None
UNII:
8D4SNN7V92
Molecule Type:
Small molecule
Molecular Formula:
C10H12O5
Molecular Weight:
212.2
AlogP:
1.37
PSA:
86.99
HBD:
3.0
HBA:
#RotB:
3.0
Source:
SGX-523
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Hepatocyte growth factor receptor inhibitor
SGX-523
×
Maximum Phase:
1
First Approval:
None
UNII:
WH8SQN09KJ
Molecule Type:
Small molecule
Molecular Formula:
C18H13N7S
Molecular Weight:
359.42
AlogP:
3.22
PSA:
73.79
HBD:
0.0
HBA:
#RotB:
3.0
Source:
MK-6592
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Serine/threonine-protein kinase Aurora inhibitor
MK-6592
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C25H26ClF2N7O2
Molecular Weight:
529.98
AlogP:
4.28
PSA:
99.27
HBD:
2.0
HBA:
#RotB:
7.0
Source:
TALADEGIB
1
Small molecule
Investigational
Unknown
Unknown
Neoplasm Metastasis; Neoplasms; Small Cell Lung Carcinoma; Idiopathic Pulmonary Fibrosis
Smoothened homolog antagonist
TALADEGIB
×
Maximum Phase:
1
First Approval:
None
UNII:
QY8BWX1LJ5
Molecule Type:
Small molecule
Molecular Formula:
C26H24F4N6O
Molecular Weight:
512.51
AlogP:
4.93
PSA:
67.15
HBD:
0.0
HBA:
#RotB:
4.0
Source:
ILX23-7553
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Vitamin D receptor agonist
ILX23-7553
×
Maximum Phase:
1
First Approval:
None
UNII:
O13QTC8612
Molecule Type:
Small molecule
Molecular Formula:
C27H38O3
Molecular Weight:
410.6
AlogP:
4.85
PSA:
60.69
HBD:
3.0
HBA:
#RotB:
3.0
Source:
BRICICLIB SODIUM
1
Small molecule
Investigational
Unknown
Unknown
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Unknown
BRICICLIB SODIUM
×
Maximum Phase:
1
First Approval:
None
UNII:
7C9N0VM8NR
Molecule Type:
Small molecule
Molecular Formula:
C19H21Na2O10PS
Molecular Weight:
518.39
AlogP:
2.78
PSA:
137.82
HBD:
2.0
HBA:
#RotB:
10.0
Source:
BMS-986166
1
Small molecule
Investigational
Unknown
Unknown
Colitis, Ulcerative
Unknown
BMS-986166
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C25H33NO2
Molecular Weight:
379.54
AlogP:
4.39
PSA:
55.48
HBD:
2.0
HBA:
#RotB:
6.0
Source:
HYDROXYNORKETAMINE, (2R,6R)-, HYDROCHLORIDE
1
Small molecule
Investigational
Unknown
Unknown
Depressive Disorder, Major
Unknown
HYDROXYNORKETAMINE, (2R,6R)-, HYDROCHLORIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C12H15Cl2NO2
Molecular Weight:
276.16
AlogP:
1.61
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
1.0
Source:
GSK159802
1
Small molecule
Investigational
Unknown
Unknown
Pulmonary Disease, Chronic Obstructive
Beta-2 adrenergic receptor agonist
GSK159802
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SGI-1776
1
Small molecule
Investigational
Unknown
Unknown
Leukemia; Lymphoma, Non-Hodgkin; Prostatic Neoplasms, Castration-Resistant
Serine/threonine-protein kinase PIM inhibitor
SGI-1776
×
Maximum Phase:
1
First Approval:
None
UNII:
72AUA0603W
Molecule Type:
Small molecule
Molecular Formula:
C20H22F3N5O
Molecular Weight:
405.42
AlogP:
4.05
PSA:
54.69
HBD:
1.0
HBA:
#RotB:
5.0
Source:
AZD-7762
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Serine/threonine-protein kinase Chk1 inhibitor
AZD-7762
×
Maximum Phase:
1
First Approval:
None
UNII:
5D822Y3L1H
Molecule Type:
Small molecule
Molecular Formula:
C17H19FN4O2S
Molecular Weight:
362.43
AlogP:
2.53
PSA:
96.25
HBD:
4.0
HBA:
#RotB:
4.0
Source:
BLI-489
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BLI-489
×
Maximum Phase:
1
First Approval:
None
UNII:
R56JYB8P8Z
Molecule Type:
Small molecule
Molecular Formula:
C13H11N3O4S
Molecular Weight:
305.31
AlogP:
0.64
PSA:
84.66
HBD:
1.0
HBA:
#RotB:
2.0
Source:
AVE-9940
1
Small molecule
Investigational
Unknown
Unknown
Unknown
MAP kinase p38 alpha inhibitor
AVE-9940
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AZD-1208
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Lymphoma; Neoplasms
Serine/threonine-protein kinase PIM inhibitor
AZD-1208
×
Maximum Phase:
1
First Approval:
None
UNII:
S98NFM1378
Molecule Type:
Small molecule
Molecular Formula:
C21H21N3O2S
Molecular Weight:
379.49
AlogP:
3.61
PSA:
75.43
HBD:
2.0
HBA:
#RotB:
3.0
Source:
BI113823
1
Small molecule
Investigational
Unknown
Unknown
Osteoarthritis
Bradykinin B1 receptor antagonist
BI113823
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PEXMETINIB
1
Small molecule
Investigational
Unknown
Unknown
Myelodysplastic Syndromes
MAP kinase p38 alpha inhibitor
PEXMETINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
3750D0U8B5
Molecule Type:
Small molecule
Molecular Formula:
C31H33FN6O3
Molecular Weight:
556.64
AlogP:
6.07
PSA:
106.23
HBD:
3.0
HBA:
#RotB:
8.0
Source:
CENICRIVIROC MESYLATE
1
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Unknown
CENICRIVIROC MESYLATE
×
Maximum Phase:
1
First Approval:
None
UNII:
R96TV84T21
Molecule Type:
Small molecule
Molecular Formula:
C42H56N4O7S2
Molecular Weight:
793.06
AlogP:
8.74
PSA:
85.69
HBD:
1.0
HBA:
#RotB:
17.0
Source:
PHENFORMIN
1
Small molecule
Investigational
Unknown
Unknown
Melanoma; Diabetes Mellitus
Unknown
PHENFORMIN
×
Maximum Phase:
1
First Approval:
None
UNII:
DD5K7529CE
Molecule Type:
Small molecule
Molecular Formula:
C10H15N5
Molecular Weight:
205.26
AlogP:
0.24
PSA:
97.78
HBD:
5.0
HBA:
#RotB:
3.0
Source:
KL-1333
1
Small molecule
Investigational
Unknown
Unknown
MELAS Syndrome; Mitochondrial Diseases
Unknown
KL-1333
×
Maximum Phase:
1
First Approval:
None
UNII:
NA2ZOL5UGM
Molecule Type:
Small molecule
Molecular Formula:
C14H12N2O2
Molecular Weight:
240.26
AlogP:
2.58
PSA:
62.82
HBD:
1.0
HBA:
#RotB:
1.0
Source:
RG7893
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Sodium channel protein type IX alpha subunit blocker
RG7893
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PL-225B
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Insulin-like growth factor I receptor inhibitor
PL-225B
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RAVOXERTINIB
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
MAP kinase ERK1 inhibitor
RAVOXERTINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
R6AXV96CRH
Molecule Type:
Small molecule
Molecular Formula:
C21H18ClFN6O2
Molecular Weight:
440.87
AlogP:
3.16
PSA:
97.86
HBD:
2.0
HBA:
#RotB:
6.0
Source:
VLX-1005
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
VLX-1005
×
Maximum Phase:
1
First Approval:
None
UNII:
JKU4XCC48Y
Molecule Type:
Small molecule
Molecular Formula:
C21H19N3O4S2
Molecular Weight:
441.53
AlogP:
4.42
PSA:
100.55
HBD:
3.0
HBA:
#RotB:
7.0
Source:
RODATRISTAT ETHYL
1
Small molecule
Investigational
Unknown
Unknown
Hypertension, Pulmonary
Tryptophan 5-hydroxylase 1 inhibitor
RODATRISTAT ETHYL
×
Maximum Phase:
1
First Approval:
None
UNII:
507FY6OL37
Molecule Type:
Small molecule
Molecular Formula:
C29H31ClF3N5O3
Molecular Weight:
590.05
AlogP:
5.57
PSA:
102.6
HBD:
2.0
HBA:
#RotB:
7.0
Source:
UK-396,082
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
UK-396,082
×
Maximum Phase:
1
First Approval:
None
UNII:
2Q5861SUIG
Molecule Type:
Small molecule
Molecular Formula:
C12H21N3O2
Molecular Weight:
239.32
AlogP:
1.28
PSA:
81.14
HBD:
2.0
HBA:
#RotB:
8.0
Source:
NANATINOSTAT
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
NANATINOSTAT
×
Maximum Phase:
1
First Approval:
None
UNII:
YTL7A418KQ
Molecule Type:
Small molecule
Molecular Formula:
C20H19FN6O2
Molecular Weight:
394.41
AlogP:
1.51
PSA:
103.27
HBD:
3.0
HBA:
#RotB:
5.0
Source:
DUBERMATINIB
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute
Unknown
DUBERMATINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
14D65TV20J
Molecule Type:
Small molecule
Molecular Formula:
C24H30ClN7O2S
Molecular Weight:
516.07
AlogP:
3.61
PSA:
93.7
HBD:
2.0
HBA:
#RotB:
8.0
Source:
BPN-14967
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BPN-14967
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ZOTATIFIN
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Severe Acute Respiratory Syndrome
Unknown
ZOTATIFIN
×
Maximum Phase:
1
First Approval:
None
UNII:
2EWN8Z05CN
Molecule Type:
Small molecule
Molecular Formula:
C28H29N3O5
Molecular Weight:
487.56
AlogP:
2.78
PSA:
108.07
HBD:
2.0
HBA:
#RotB:
6.0
Source:
ABT-107
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Neuronal acetylcholine receptor protein alpha-7 subunit agonist
ABT-107
×
Maximum Phase:
1
First Approval:
None
UNII:
SXS38HR98H
Molecule Type:
Small molecule
Molecular Formula:
C19H20N4O
Molecular Weight:
320.4
AlogP:
3.1
PSA:
54.04
HBD:
1.0
HBA:
#RotB:
3.0
Source:
LY-3009120
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Melanoma; Neoplasm Metastasis
Serine/threonine-protein kinase A-Raf inhibitor
LY-3009120
×
Maximum Phase:
1
First Approval:
None
UNII:
1GDT36RARO
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
61
62
63
64
65
66
67
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA